November 3, 2005

SpeculatingStocks.com Stock Pick: Cholestech Corporation (CTEC)

Stock Price: $8.63 (long-term strong buy)

Cholestech Corporation provides easy to use, accessible diagnostic tools and information to health care practitioners in over 35 countries around the world. The company offers efficient and economic diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, and liver function at the point of care.

CTEC is bottoming about $1 above its 52-week low and is trading at a PE of only 19. The company just reported their second quarter results, revenue came in at $15.3 million and profit at $1.6 million. Revenue increase by 13% and profit by 60% over the same period last year.

Cholestech has a strong balance sheet with assets far exceeding liabilities and cash of $37.5 million.

SpeculatingStocks.com Target Price: We expect CTEC to reach $12 within the next 2 - 4 months.